V. Malerczyk

774 total citations
46 papers, 575 citations indexed

About

V. Malerczyk is a scholar working on Pharmacology, Pharmacology and Molecular Medicine. According to data from OpenAlex, V. Malerczyk has authored 46 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 9 papers in Pharmacology and 9 papers in Molecular Medicine. Recurrent topics in V. Malerczyk's work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Antibiotic Resistance in Bacteria (9 papers) and Pharmacogenetics and Drug Metabolism (9 papers). V. Malerczyk is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (23 papers), Antibiotic Resistance in Bacteria (9 papers) and Pharmacogenetics and Drug Metabolism (9 papers). V. Malerczyk collaborates with scholars based in Germany, Belgium and Austria. V. Malerczyk's co-authors include A. Korn, M. Verho, Karl‐Heinz Lehr, M. Badian, W Waldhäusl, Bernd Rosenkranz, Claudia Lange, Paul H. Heintzen, Péter Hajdú and K. W. Scheel and has published in prestigious journals such as Diabetologia, Clinical Pharmacology & Therapeutics and Journal of Antimicrobial Chemotherapy.

In The Last Decade

V. Malerczyk

44 papers receiving 503 citations

Peers

Countries citing papers authored by V. Malerczyk

Since Specialization

Citations

This map shows the geographic impact of V. Malerczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Malerczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Malerczyk more than expected).

Fields of papers citing papers by V. Malerczyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Malerczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Malerczyk. The network helps show where V. Malerczyk may publish in the future.

Co-authorship network of co-authors of V. Malerczyk

This figure shows the co-authorship network connecting the top 25 collaborators of V. Malerczyk. A scholar is included among the top collaborators of V. Malerczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Malerczyk. V. Malerczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetics of Levofloxacin in Comparison to the Racemic Mixture of Ofloxacin in Man 1996 ·Drug metabolism and drug interactions ·M. Verho, V. Malerczyk, Douglas D Damm, (unknown)	10
2	Pharmacokinetics and Pharmacodynamics of the Hydroxy-Metabolite of Glimepiride (Amaryl®) After Intravenous Administration 1996 ·Drug metabolism and drug interactions ·M. Badian, A. Korn, Karl‐Heinz Lehr, V. Malerczyk, W Waldhäusl	21
3	Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment 1996 ·Diabetologia ·Bernd Rosenkranz, (unknown), (unknown), (unknown), Claudia Lange, V. Malerczyk	74
4	DOSE LINEARITY ASSESSMENT OF GLIMEPIRIDE (AMARYL®) TABLETS IN HEALTHY VOLUNTEERS 1994 ·Drug metabolism and drug interactions ·V. Malerczyk, M. Badian, A. Korn, Karl‐Heinz Lehr, W Waldhäusl	36
5	ABSOLUTE BIOAVAILABILITY OF GLIMEPIRIDE (AMARYL®) AFTER ORAL ADMINISTRATION 1994 ·Drug metabolism and drug interactions ·M. Badian, A. Korn, Karl‐Heinz Lehr, V. Malerczyk, W Waldhäusl	42
6	Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysis 1993 ·Clinical Pharmacology & Therapeutics ·Nic Veys, Norbert Lameire, V. Malerczyk, (unknown), Bernd Rosenkranz, S Ringoir	5
7	Pharmacokinetic investigations of the α-human thrombin-hirudin complex in rhesus monkeys 1992 ·Thrombosis Research ·(unknown), M. Hropot, (unknown), (unknown), V. Malerczyk, (unknown), (unknown), (unknown)	3
8	Single-dose pharmacokinetics of cefpirome in patients with renal impairment 1992 ·Clinical Pharmacology & Therapeutics ·Norbert Lameire, V. Malerczyk, (unknown), (unknown), Bernd Rosenkranz	10
9	Ofloxacin Pharmacokinetics in Chronic Renal Failure and Dialysis 1991 ·Clinical Pharmacokinetics ·Norbert Lameire, Bernd Rosenkranz, V. Malerczyk, Karl‐Heinz Lehr, Nic Veys, S Ringoir	17
10	Pharmacokinetics of cefodizime during continuous ambulatory peritoneal dialysis 1990 ·Journal of Antimicrobial Chemotherapy ·Paul Mendes, Norbert Lameire, Bernd Rosenkranz, V. Malerczyk, Douglas D Damm	5
11	Dose Linearity Testing of Intravenous Ofloxacin, a Novel Gyrase Inhibitor 1988 ·Chemotherapy ·M. Verho, A. Korn, M. Badian, V. Malerczyk, W. Waldhäusl	4
12	Safety, Tolerance and Pharmacokinetics of 2.0 g Cefpirome (HR 810) after Single and Multiple Dosing 1988 ·Chemotherapy ·M. Badian, V. Malerczyk, (unknown), (unknown), M. Verho, H. G. Eckert	14
13	Influence of experimental rhinitis on the gonadotropin response to intranasal administration of buserelin 1987 ·European Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), Niels Mygind, (unknown), H.-G. Grigoleit, V. Malerczyk	19
14	[Combination of alcohol and piracetam]. 1987 ·PubMed ·M. Badian, (unknown), V. Malerczyk, (unknown), (unknown)	0
15	The Effects of 75 Mg HOE 760, a Novel H₂-Receptor Antagonist, on Daytime Peptone-Stimulated and Nocturnal Gastric Acid Output in Healthy Volunteers 1987 ·Scandinavian Journal of Gastroenterology ·F. Hagenmüller, (unknown), Simone Hausmann, (unknown), V. Malerczyk, (unknown), M. Claßen	3
16	Multiple dose comparison of two oral formulations of the Salidiuretic Piretanide. 1984 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·F. O. Müller, (unknown), H.-G. Grigoleit, W. Heptner, V. Malerczyk, (unknown)	4
17	Concentrations of cefotaxime in skin 1980 ·Infection ·(unknown), D Petzoldt, V. Malerczyk, K. Seeger, (unknown)	5
18	[Blood, urine and bile levels of ampicillin during continuous intravenous infusion]. 1975 ·PubMed ·Violette C. Simon, V. Malerczyk, (unknown), (unknown), (unknown)	4
19	Zur Pharmakokinetik von Clindamycin bei gestörter Leber- und Nierenfunktion 1972 ·DMW - Deutsche Medizinische Wochenschrift ·Richard Brandl, (unknown), Carlos Simón, V. Malerczyk, (unknown)	10
20	On-line processing of the video-image for left ventricular volume determination 1971 ·Computers and Biomedical Research ·Paul H. Heintzen, V. Malerczyk, (unknown), K. W. Scheel	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact